This is particularly justified by a number of publications hinting at the reduced expression of SYNPO2 in a variety of tumors, leading to the assumption that it may act as a tumor suppressor (e.g., ref. [29,49,50,51]). The gene discussed is SYNPO2; the disease is neoplasm.